Fate Therapeutics (FATE) Short Interest Ratio & Short Volume → 4 coins to be the “Next Bitcoin” (From True Market Insiders) (Ad) Free FATE Stock Alerts $3.80 -0.07 (-1.81%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Fate Therapeutics Short Interest DataCurrent Short Volume18,920,000 sharesPrevious Short Volume16,490,000 sharesChange Vs. Previous Month+14.74%Dollar Volume Sold Short$106.71 millionShort Interest Ratio / Days to Cover6.8Last Record DateApril 15, 2024Outstanding Shares113,820,000 sharesPercentage of Shares Shorted16.62%Today's Trading Volume2,732,203 sharesAverage Trading Volume2,131,925 sharesToday's Volume Vs. Average128% Short Selling Fate Therapeutics ? Sign up to receive the latest short interest report for Fate Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFATE Short Interest Over TimeFATE Days to Cover Over TimeFATE Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Fate Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202418,920,000 shares $106.71 million +14.7%N/A6.8 $5.64 3/31/202416,490,000 shares $121.04 million +25.3%19.0%5.8 $7.34 3/15/202413,160,000 shares $98.57 million -2.5%15.2%4.6 $7.49 2/29/202413,490,000 shares $95.64 million +1.4%15.6%5.1 $7.09 2/15/202413,310,000 shares $94.23 million +15.9%15.5%5.3 $7.08 1/31/202411,480,000 shares $70.72 million +6.6%12.4%4.7 $6.16 Get the Latest News and Ratings for FATE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202410,770,000 shares $49.00 million +2.1%11.6%5.3 $4.55 12/31/202310,550,000 shares $39.46 million -2.1%11.4%5.8 $3.74 12/15/202310,780,000 shares $32.56 million -7.9%11.6%6.3 $3.02 11/30/202311,710,000 shares $29.16 million +0.9%12.6%5.6 $2.49 11/15/202311,610,000 shares $28.79 million -1.6%12.5%5.3 $2.48 10/31/202311,800,000 shares $21.36 million -14.5%12.7%5.2 $1.81 10/15/202313,800,000 shares $23.46 million -7.4%14.9%6.1 $1.70 9/30/202314,900,000 shares $31.59 million -38.7%16.1%6.6 $2.12 9/15/202324,290,000 shares $53.44 million -12.1%26.2%10.7 $2.20 8/31/202327,640,000 shares $69.38 million -2.3%29.8%12.7 $2.51 8/15/202328,290,000 shares $82.89 million +2.4%30.5%13.2 $2.93 7/31/202327,630,000 shares $114.11 million +7.6%29.9%12.9 $4.13 7/15/202325,670,000 shares $121.42 million -1.0%27.8%11.5 $4.73 6/30/202325,930,000 shares $123.43 million -11.9%28.1%10.6 $4.76 6/15/202329,440,000 shares $171.05 million +1.1%31.9%11.7 $5.81 5/31/202329,120,000 shares $147.06 million 0.0%31.5%11.2 $5.05 5/15/202329,130,000 shares $155.26 million +3.7%31.6%10.8 $5.33 4/30/202328,080,000 shares $170.45 million +4.3%30.7%10.3 $6.07 4/15/202326,920,000 shares $161.79 million -1.5%29.5%9.7 $6.01 3/31/202327,340,000 shares $155.84 million +26.7%30.0%9.1 $5.70 3/15/202321,580,000 shares $119.98 million +15.7%23.6%5.4 $5.56 2/28/202318,660,000 shares $114.20 million +10.7%20.4%5.1 $6.12 2/15/202316,850,000 shares $106.83 million +3.5%18.7%4.9 $6.34 1/31/202316,280,000 shares $97.03 million +5.4%17.8%4.9 $5.96 1/15/202315,450,000 shares $83.43 million -30.8%16.9%4.9 $5.40 12/30/202222,330,000 shares $225.31 million +10.3%24.5%7.8 $10.09 12/15/202220,240,000 shares $287.61 million -4.6%22.2%13.5 $14.21 11/30/202221,220,000 shares $441.80 million -4.1%23.2%16.6 $20.82 11/15/202222,120,000 shares $492.83 million -0.5%24.2%16.8 $22.28 10/31/202222,230,000 shares $465.05 million +2.1%24.4%16.3 $20.92 10/15/202221,780,000 shares $443.44 million +0.7%24.0%16.5 $20.36 9/30/202221,620,000 shares $484.50 million +3.9%23.8%16.5 $22.41 9/15/202220,800,000 shares $562.64 million +2.8%22.9%15 $27.05 8/31/202220,240,000 shares $529.07 million +1.6%22.3%13.6 $26.14These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy FATE Short Interest - Frequently Asked Questions What is Fate Therapeutics' current short interest? Short interest is the volume of Fate Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 18,920,000 shares of FATE short. Learn More on Fate Therapeutics' current short interest. What is a good short interest ratio for Fate Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FATE shares currently have a short interest ratio of 7.0. Learn More on Fate Therapeutics's short interest ratio. Which institutional investors are shorting Fate Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fate Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Fate Therapeutics' short interest increasing or decreasing? Fate Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 18,920,000 shares, an increase of 14.7% from the previous total of 16,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Fate Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Fate Therapeutics: Alector, Inc. (9.48%), Exscientia plc (3.70%), Valneva SE (0.07%), C4 Therapeutics, Inc. (13.94%), Taysha Gene Therapies, Inc. (8.59%), Humacyte, Inc. (4.38%), Allogene Therapeutics, Inc. (29.95%), ProKidney Corp. (26.69%), Editas Medicine, Inc. (22.81%), Novavax, Inc. (31.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Fate Therapeutics stock? Short selling FATE is an investing strategy that aims to generate trading profit from Fate Therapeutics as its price is falling. FATE shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fate Therapeutics? A short squeeze for Fate Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FATE, which in turn drives the price of the stock up even further. How often is Fate Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FATE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ALEC Short Squeeze EXAI Short Squeeze VALN Short Squeeze CCCC Short Squeeze TSHA Short Squeeze HUMA Short Squeeze ALLO Short Squeeze PROK Short Squeeze EDIT Short Squeeze NVAX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FATE) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressHas Jeff Bezos Found the Next Nvidia?InvestorPlace